Review



wuhan wt spike rbd  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    R&D Systems wuhan wt spike rbd
    Avidity-driven binding of ACE2 decoys to SARS-CoV-2 <t>Wuhan</t> (WT) strain <t>spike</t> <t>RBD</t> increases with higher ACE2 valency.
    Wuhan Wt Spike Rbd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spike+rbd+proteins+for+wuhan+wt/Recombinant+SARS-CoV-2+Spike+RBD+His-tag+Protein%2C+CF/pmc10215022-186-22-27
    Average 92 stars, based on 16 article reviews
    wuhan wt spike rbd - by Bioz Stars, 2026-10
    92/100 stars

    Images

    1) Product Images from "Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2"

    Article Title: Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2

    Journal: mAbs

    doi: 10.1080/19420862.2023.2212415

    Avidity-driven binding of ACE2 decoys to SARS-CoV-2 Wuhan (WT) strain spike RBD increases with higher ACE2 valency.
    Figure Legend Snippet: Avidity-driven binding of ACE2 decoys to SARS-CoV-2 Wuhan (WT) strain spike RBD increases with higher ACE2 valency.

    Techniques Used: Binding Assay

    Binding kinetics of ACE2 decoy variants and clinical comparators to recombinant spike protein RBD as measured by SPR.
    Figure Legend Snippet: Binding kinetics of ACE2 decoy variants and clinical comparators to recombinant spike protein RBD as measured by SPR.

    Techniques Used: Binding Assay, Recombinant, Control

    Related Articles

    Binding Assay:

    Article Title: Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
    Article Snippet: SPR affinity measurements for the ACE2 decoys and controls were performed using a Biacore T200 instrument (Cytiva) at 25°C using HBS EP+ buffer (#BR100669, Cytiva).SPR affinity measurements for the ACE2 decoys and controls were performed using a Biacore T200 instrument (Cytiva) at 25°C using HBS EP+ buffer (#BR100669, Cytiva).. His-tagged spike RBD proteins for Wuhan (WT) (#10500-CV, R&D Systems), Delta (B.1.617.2) (#10876-CV, R&D Systems), Omicron (B.1.1.529) (#40592-V08H121, Sino Biological), Alpha (B.1.1.7) (#10730-CV, R&D Systems), Beta (B.1.351) (#10735-CV, R&D Systems), and Gamma (P.1) (#10775-CV, R&D Systems) were each covalently immobilized on a CM5 Series S sensor chip by amine coupling to ligand density of ~ 100 RU.. To measure avidity-driven binding of multivalent ACE2 decoys, as a series of captured spike RBD protein levels were generated by covalently immobilizing Wuhan (WT) spike RBD (#10500-CV, R&D Systems on CM5 Series S sensor chip to ligand densities of ~7, 15, 100, and 400 RU.To measure avidity-driven binding of multivalent ACE2 decoys, as a series of captured spike RBD protein levels were generated by covalently immobilizing Wuhan (WT) spike RBD (#10500-CV, R&D Systems on CM5 Series S sensor chip to ligand densities..

    Recombinant:

    Article Title: Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
    Article Snippet: SPR affinity measurements for the ACE2 decoys and controls were performed using a Biacore T200 instrument (Cytiva) at 25°C using HBS EP+ buffer (#BR100669, Cytiva).SPR affinity measurements for the ACE2 decoys and controls were performed using a Biacore T200 instrument (Cytiva) at 25°C using HBS EP+ buffer (#BR100669, Cytiva).. His-tagged spike RBD proteins for Wuhan (WT) (#10500-CV, R&D Systems), Delta (B.1.617.2) (#10876-CV, R&D Systems), Omicron (B.1.1.529) (#40592-V08H121, Sino Biological), Alpha (B.1.1.7) (#10730-CV, R&D Systems), Beta (B.1.351) (#10735-CV, R&D Systems), and Gamma (P.1) (#10775-CV, R&D Systems) were each covalently immobilized on a CM5 Series S sensor chip by amine coupling to ligand density of ~ 100 RU.. To measure avidity-driven binding of multivalent ACE2 decoys, as a series of captured spike RBD protein levels were generated by covalently immobilizing Wuhan (WT) spike RBD (#10500-CV, R&D Systems on CM5 Series S sensor chip to ligand densities of ~7, 15, 100, and 400 RU.To measure avidity-driven binding of multivalent ACE2 decoys, as a series of captured spike RBD protein levels were generated by covalently immobilizing Wuhan (WT) spike RBD (#10500-CV, R&D Systems on CM5 Series S sensor chip to ligand densities..

    Control:

    Article Title: Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
    Article Snippet: SPR affinity measurements for the ACE2 decoys and controls were performed using a Biacore T200 instrument (Cytiva) at 25°C using HBS EP+ buffer (#BR100669, Cytiva).SPR affinity measurements for the ACE2 decoys and controls were performed using a Biacore T200 instrument (Cytiva) at 25°C using HBS EP+ buffer (#BR100669, Cytiva).. His-tagged spike RBD proteins for Wuhan (WT) (#10500-CV, R&D Systems), Delta (B.1.617.2) (#10876-CV, R&D Systems), Omicron (B.1.1.529) (#40592-V08H121, Sino Biological), Alpha (B.1.1.7) (#10730-CV, R&D Systems), Beta (B.1.351) (#10735-CV, R&D Systems), and Gamma (P.1) (#10775-CV, R&D Systems) were each covalently immobilized on a CM5 Series S sensor chip by amine coupling to ligand density of ~ 100 RU.. To measure avidity-driven binding of multivalent ACE2 decoys, as a series of captured spike RBD protein levels were generated by covalently immobilizing Wuhan (WT) spike RBD (#10500-CV, R&D Systems on CM5 Series S sensor chip to ligand densities of ~7, 15, 100, and 400 RU.To measure avidity-driven binding of multivalent ACE2 decoys, as a series of captured spike RBD protein levels were generated by covalently immobilizing Wuhan (WT) spike RBD (#10500-CV, R&D Systems on CM5 Series S sensor chip to ligand densities..



    Similar Products

    wuhan wt spike rbd  (R&D Systems)
    92
    R&D Systems wuhan wt spike rbd
    Avidity-driven binding of ACE2 decoys to SARS-CoV-2 <t>Wuhan</t> (WT) strain <t>spike</t> <t>RBD</t> increases with higher ACE2 valency.
    Wuhan Wt Spike Rbd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spike+rbd+proteins+for+wuhan+wt/Recombinant+SARS-CoV-2+Spike+RBD+His-tag+Protein%2C+CF/pmc10215022-186-22-27
    Average 92 stars, based on 1 article reviews
    wuhan wt spike rbd - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier
    spike rbd proteins for wuhan wt  (R&D Systems)
    92
    R&D Systems spike rbd proteins for wuhan wt
    Avidity-driven binding of ACE2 decoys to SARS-CoV-2 <t>Wuhan</t> (WT) strain spike <t>RBD</t> increases with higher ACE2 valency.
    Spike Rbd Proteins For Wuhan Wt, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/spike+rbd+proteins+for+wuhan+wt/Recombinant+SARS-CoV-2+Spike+RBD+His-tag+Protein%2C+CF/pmc10215022-185-1-8
    Average 92 stars, based on 1 article reviews
    spike rbd proteins for wuhan wt - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    Avidity-driven binding of ACE2 decoys to SARS-CoV-2 Wuhan (WT) strain spike RBD increases with higher ACE2 valency.

    Journal: mAbs

    Article Title: Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2

    doi: 10.1080/19420862.2023.2212415

    Figure Lengend Snippet: Avidity-driven binding of ACE2 decoys to SARS-CoV-2 Wuhan (WT) strain spike RBD increases with higher ACE2 valency.

    Article Snippet: To measure avidity-driven binding of multivalent ACE2 decoys, as a series of captured spike RBD protein levels were generated by covalently immobilizing Wuhan (WT) spike RBD (#10500-CV, R&D Systems on CM5 Series S sensor chip to ligand densities of ~7, 15, 100, and 400 RU.

    Techniques: Binding Assay

    Binding kinetics of ACE2 decoy variants and clinical comparators to recombinant spike protein RBD as measured by SPR.

    Journal: mAbs

    Article Title: Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2

    doi: 10.1080/19420862.2023.2212415

    Figure Lengend Snippet: Binding kinetics of ACE2 decoy variants and clinical comparators to recombinant spike protein RBD as measured by SPR.

    Article Snippet: To measure avidity-driven binding of multivalent ACE2 decoys, as a series of captured spike RBD protein levels were generated by covalently immobilizing Wuhan (WT) spike RBD (#10500-CV, R&D Systems on CM5 Series S sensor chip to ligand densities of ~7, 15, 100, and 400 RU.

    Techniques: Binding Assay, Recombinant, Control

    Avidity-driven binding of ACE2 decoys to SARS-CoV-2 Wuhan (WT) strain spike RBD increases with higher ACE2 valency.

    Journal: mAbs

    Article Title: Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2

    doi: 10.1080/19420862.2023.2212415

    Figure Lengend Snippet: Avidity-driven binding of ACE2 decoys to SARS-CoV-2 Wuhan (WT) strain spike RBD increases with higher ACE2 valency.

    Article Snippet: His-tagged spike RBD proteins for Wuhan (WT) (#10500-CV, R&D Systems), Delta (B.1.617.2) (#10876-CV, R&D Systems), Omicron (B.1.1.529) (#40592-V08H121, Sino Biological), Alpha (B.1.1.7) (#10730-CV, R&D Systems), Beta (B.1.351) (#10735-CV, R&D Systems), and Gamma (P.1) (#10775-CV, R&D Systems) were each covalently immobilized on a CM5 Series S sensor chip by amine coupling to ligand density of ~ 100 RU.

    Techniques: Binding Assay

    Binding kinetics of ACE2 decoy variants and clinical comparators to recombinant spike protein RBD as measured by SPR.

    Journal: mAbs

    Article Title: Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2

    doi: 10.1080/19420862.2023.2212415

    Figure Lengend Snippet: Binding kinetics of ACE2 decoy variants and clinical comparators to recombinant spike protein RBD as measured by SPR.

    Article Snippet: His-tagged spike RBD proteins for Wuhan (WT) (#10500-CV, R&D Systems), Delta (B.1.617.2) (#10876-CV, R&D Systems), Omicron (B.1.1.529) (#40592-V08H121, Sino Biological), Alpha (B.1.1.7) (#10730-CV, R&D Systems), Beta (B.1.351) (#10735-CV, R&D Systems), and Gamma (P.1) (#10775-CV, R&D Systems) were each covalently immobilized on a CM5 Series S sensor chip by amine coupling to ligand density of ~ 100 RU.

    Techniques: Binding Assay, Recombinant, Control